Catheter Precision Inc. (NYSE American: VTAK) received a Notice of Allowance from the United States Patent and Trademark Office for claims covering its surgical vessel closing pressure device, according to a company statement.

The USPTO confirmed the novelty and patentability of the technology following examination. The allowed claims provide protection for both the device architecture and its method of use.

The patented system features a design for controlling suture tension and pressure application after vascular procedures to support hemostasis. The protection covers structural and functional elements of the technology.

"This milestone further underscores Catheter Precision's commitment to innovation and strengthens its foundation for driving significant long-term shareholder value," said David A. Jenkins, Chief Executive Officer of Catheter Precision.

The Fort Mill, South Carolina-based company develops medical devices for cardiac arrhythmia treatment. Its LockeT product is a suture retention device for wound closure after percutaneous venous punctures that is registered with the FDA as a Class 1 device and has received CE Mark approval.

The information is based on a company press release statement.